| Filed On | Filing |
|---|---|
| 14 Aug 2024 |
Form 3: Citius Pharmaceuticals, Inc., 10% owner · Citius Oncology Inc
Holds 65,627,262 shares of Common Stock |
| 18 Mar 2024 |
Form 3: Smith Robert Joseph, Director
No securities owned |
| 09 Feb 2023 |
Form 3: Mcgrath Dennis M, Director
No securities owned |
| 15 Jul 2020 |
Form 3: Czuczman Myron, Chief Medical Officer
No securities owned |
| 13 Dec 2017 |
Form 3: Bartushak Jaime, Chief Financial Officer
Holds 60,353 shares of Common Stock |
| 29 Jun 2016 | Form 3: Holuka Eugene Myron, Director |
| 19 Apr 2016 | Form 3: Kane William, Director |
| 15 Apr 2016 | Form 3: Webb Carol, Director |
| 11 Apr 2016 | Form 3: Safir Howard, Director |
| 04 Nov 2015 | Form 3: Dutia Suren G, Director |
| 28 Oct 2015 |
Form 3: Mazur Leonard L, Director
Holds 457,143 shares of Common Stock |
| 27 Oct 2015 | Form 3: Holubiak Myron Z, Director |
Loading...
